Chia Tai Enterprises International ( (HK:3839) ) has provided an update.
Chia Tai Enterprises International Limited has announced a revision of its annual caps for the years 2025 and 2026 under the 2023 Master HOEL Purchase Agreement due to a significant increase in sales to the HOEL Group. The company plans to increase the caps from the existing US$194.3 million and US$218.8 million to US$506.1 million and US$556.7 million respectively, reflecting anticipated growth in demand for its animal health products. This strategic move is expected to enhance the company’s market position and meet the expanding business needs of the HOEL Group, as well as accommodate potential increases in market prices and demand.
More about Chia Tai Enterprises International
Chia Tai Enterprises International Limited is an investment holding company with subsidiaries primarily engaged in the manufacture and sale of animal health products and chlortetracycline products. The company is also involved in the trading of machinery and the manufacture and sale of automotive parts through its joint venture and associated company.
Technical Sentiment Signal: Buy
Current Market Cap: $52.46M
Learn more about 3839 stock on TipRanks’ Stock Analysis page.